Status:
COMPLETED
Compliance to Artesunate-Amodiaquine Therapy for Uncomplicated Malaria in Rural Ghana
Lead Sponsor:
Kintampo Health Research Centre, Ghana
Collaborating Sponsors:
London School of Hygiene and Tropical Medicine
Conditions:
Malaria
Eligibility:
All Genders
10+ years
Brief Summary
With a change in malaria treatment policy to use combination antimalaria therapy, it is envisaged that compliance to combination therapy would be less than that of monotherapy that was being used for ...
Detailed Description
Primary objective: • To determine compliance to artesunate-amodiaquine therapy among patients diagnosed with acute uncomplicated malaria in the Kintampo District Hospital. Secondary objectives: 1. ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Male and female patients aged above ten years reporting at the Kintampo district hospital.
- Diagnosed as having Plasmodium falciparum uncomplicated malaria.
- Axillary temperature ≥37.5oC but less than 40 oC or history of fever in preceding 24 hr.
- Ability to tolerate oral therapy.
- Patient who live and can be located in the Kintampo District.
- Consent of patient and/or care giver (in the case of children)
- Exclusion criteria:
- Pregnant women.
- Children ten years and below (to be catered for in the child antimalarial efficacy studies mentioned above).
Exclusion
Key Trial Info
Start Date :
October 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
411 Patients enrolled
Trial Details
Trial ID
NCT00873938
Start Date
October 1 2005
End Date
September 1 2006
Last Update
April 30 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kintampo Health Research Centre
Brong Ahafo Region, Kintampo, Ghana